180 related articles for article (PubMed ID: 33789374)
1. [Effect of long non-coding RNA MBNL1-AS1 expression on prognosis of acute myeloid leukemia patients].
Xie W; Qian TT; Pang Y; Ye X; Huang WH; Zhu P; Fu L
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(13):934-938. PubMed ID: 33789374
[No Abstract] [Full Text] [Related]
2. Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1.
Cheng Z; Dai Y; Pang Y; Jiao Y; Zhao H; Wu S; Zhang L; Zhang Y; Wang X; Wang L; Ma D; Qin T; Hu N; Zhang Y; Hu K; Zhang Q; Shi J; Fu L
Cell Physiol Biochem; 2018; 47(5):1853-1861. PubMed ID: 29961066
[TBL] [Abstract][Full Text] [Related]
3. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
4. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
[TBL] [Abstract][Full Text] [Related]
6. [Survival efficacy of MDS/AML patients with TP53 abnormal received allogeneic hematopoietic stem cell transplantation].
Feng D; Wang MY; Liu J; Zhang HX; Chen X; Zhang RL; Zhai WH; Ma QL; Pang AM; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):222-229. PubMed ID: 37356984
[No Abstract] [Full Text] [Related]
7. Prognostic value of the FUT family in acute myeloid leukemia.
Dai Y; Cheng Z; Pang Y; Jiao Y; Qian T; Quan L; Cui L; Liu Y; Si C; Chen J; Ye X; Chen J; Shi J; Wu D; Zhang X; Fu L
Cancer Gene Ther; 2020 Feb; 27(1-2):70-80. PubMed ID: 31209266
[TBL] [Abstract][Full Text] [Related]
8. MiR-425 expression profiling in acute myeloid leukemia might guide the treatment choice between allogeneic transplantation and chemotherapy.
Yang C; Shao T; Zhang H; Zhang N; Shi X; Liu X; Yao Y; Xu L; Zhu S; Cao J; Cheng H; Yan Z; Li Z; Niu M; Xu K
J Transl Med; 2018 Oct; 16(1):267. PubMed ID: 30285885
[TBL] [Abstract][Full Text] [Related]
9. High expression of AK1 predicts inferior prognosis in acute myeloid leukemia patients undergoing chemotherapy.
Qin T; Zhao H; Shao Y; Hu N; Shi J; Fu L; Zhang Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32519744
[TBL] [Abstract][Full Text] [Related]
10. lncRNA FBXL19-AS1 is a diagnosis biomarker for paediatric patients with acute myeloid leukemia.
Sheng H; Zhang J; Ma Y; Zhang Y; Dai Y; Jiang R
J Gene Med; 2021 Mar; 23(3):e3317. PubMed ID: 33474753
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of lncRNA DLEU7-AS1 is a novel favorable prognostic factor in acute myeloid leukemia.
Wang CZ; Ma BB; Xu ZJ; Zhou JD; Zhang TJ; Chen Q; Yao DM; Lin J; Qian J; Sha S
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35506368
[TBL] [Abstract][Full Text] [Related]
12. Identification of long non-coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia.
Jiang Z; Yu Q; Luo X
J Clin Lab Anal; 2020 Apr; 34(4):e23113. PubMed ID: 31724217
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA taurine-upregulated gene 1 correlates with unfavorable prognosis in patients with refractory or relapsed acute myeloid leukemia treated by purine analogue based chemotherapy regimens.
Luo W; Yu H; Zou X; Ni X; Wei J
Cancer Biomark; 2018; 23(4):485-494. PubMed ID: 30347595
[TBL] [Abstract][Full Text] [Related]
14. [The Prognostic Value of FOSB Gene in Acute Myeloid Leukemia].
Luan SH; Ma YQ; Yang JJ; Wang H; Liu DH; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1063-1070. PubMed ID: 35981363
[TBL] [Abstract][Full Text] [Related]
15. [Overexpression of LncRNA ITGB2-AS1 Predicts Adverse Prognosis in Acute Myeloid Leukemia].
Zhou YL; Xu ZJ; Zhou JD; Zhang TJ; Yao DM; Ma JC; Lin J; Qian J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1436-1449. PubMed ID: 34627422
[TBL] [Abstract][Full Text] [Related]
16. High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia.
Liu Y; Lu R; Cui W; Pang Y; Liu C; Cui L; Qian T; Quan L; Dai Y; Jiao Y; Pan Y; Ye X; Shi J; Cheng Z; Fu L
Cancer Gene Ther; 2020 Feb; 27(1-2):38-44. PubMed ID: 30923336
[TBL] [Abstract][Full Text] [Related]
17. High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.
Liu Y; Cao Y; Yang X; Chen H; Yang H; Liu Y; Gu W
Transl Cancer Res; 2023 Apr; 12(4):913-927. PubMed ID: 37180663
[TBL] [Abstract][Full Text] [Related]
18. Higher expression of programmed cell death 4 (PDCD4) in acute myeloid leukemia is associated with better prognosis after chemotherapy.
Tang H; Chen Y; Zhang N; Deng J; Zhou K
Ann Hematol; 2023 Dec; 102(12):3401-3412. PubMed ID: 37878012
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis on adult acute T-lymphoblastic leukemia].
Zhang Q; Zhou CL; Fu MW; Wang JY; Lin D; Liu BC; Li W; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):478-82. PubMed ID: 22541122
[TBL] [Abstract][Full Text] [Related]
20. Long non‑coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia.
Tan Z; Zhu K; Yin Y; Luo Z
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
